Cangrelor Bridging Within 6 Months of a Drug-Eluting Stent in a Patient for Emergency Cervical Spine Surgery: A Case Report.

A A Pract 2019 Jul;13(2):69-73

Cardiovascular Disease, University of California, Los Angeles, California.

The recommended duration of dual antiplatelet therapy after drug-eluting stent placement presents a dilemma for patients with recent stenting who require urgent or emergency noncardiac surgery. We present the case of a patient with recent drug-eluting stent placement (<6 months) on dual antiplatelet therapy who underwent successful emergency cervical spine surgery with antiplatelet therapy bridged using cangrelor, an intravenous P2Y12 inhibitor antiplatelet agent. Our experience illustrates the multidisciplinary approach to a patient with high thrombotic and bleeding risk who underwent neurosurgery off both aspirin and a P2Y12 inhibitor.

Download full-text PDF

Source
http://dx.doi.org/10.1213/XAA.0000000000000994DOI Listing
July 2019

Publication Analysis

Top Keywords

drug-eluting stent
12
stent placement
8
surgery case
8
recommended duration
4
require urgent
4
duration dual
4
urgent emergency
4
report recommended
4
emergency noncardiac
4
bridging months
4
dual antiplatelet
4
stenting require
4
patients stenting
4
presents dilemma
4
placement presents
4
cangrelor bridging
4
antiplatelet therapy
4
therapy drug-eluting
4
dilemma patients
4
case report
4

Similar Publications